Literature DB >> 18297425

Neuropsychological and hypothalamic-pituitary-axis function in female patients with melancholic and non-melancholic depression.

Ioannis Michopoulos1, Iannis M Zervas, Chris Pantelis, Eleftheria Tsaltas, Vassiliki-Maria Papakosta, Fotini Boufidou, Chrissoula Nikolaou, Charalambos Papageorgiou, Costas R Soldatos, Lefteris Lykouras.   

Abstract

BACKGROUND: Executive function deficits in depression implicate involvement of frontal-striatal circuits. However, studies of hypothalamic-pituitary-axis (HPA) function suggest that stress-related brain changes of hippocampus may also implicate prefrontal-hippocampal circuits, which may explain the profile of both executive dysfunction and memory deficits. In this study we examined the performance of patients with major depressive disorder (MDD) on tasks of memory and executive function in relation to melancholic features and to cortisol levels. Our hypothesis was that raised cortisol levels in melancholic patients would correlate with these deficits.
METHOD: Forty female MDD patients, 20 having melancholic features (MEL vs. Non-MEL), and 20 sex-age- and education-matched normal controls were investigated using the Cambridge neuropsychological test automated battery (CANTAB), to assess memory (paired associative learning, PAL; short-term recognition memory, SRM) and executive (intradimensional/extradimensional set-shifting, ID/ED; Stockings of Cambridge, SOC) functions. Plasma and salivary cortisol levels were measured.
RESULTS: The MDD patients performed worse than controls on PAL and both executive tasks. The MEL group differed from controls on all tests, and differed from the non-MEL only at the ED stage of the ID/ED task. Patient cortisol levels were within the normal range and did not correlate with neuropsychological performance for any group.
CONCLUSIONS: MDD patients showed neuropsychological deficits on tasks of executive function and memory, supporting the model of frontal-temporal dysfunction. MEL vs. non-MEL performed worse overall and demonstrated a qualitative difference in set shifting, perhaps implicating more extensive prefrontal involvement. Cortisol levels did not correlate with depression severity or the observed deficits.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297425     DOI: 10.1007/s00406-007-0781-8

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  61 in total

1.  Nondementing psychoses in older persons.

Authors:  J J MADDEN; J A LUHAN; L A KAPLAN; H M MANFREDI
Journal:  J Am Med Assoc       Date:  1952-12-20

2.  Transferrin enzyme immunoassay for quantitative monitoring of blood contamination in saliva.

Authors:  Eve B Schwartz; Douglas A Granger
Journal:  Clin Chem       Date:  2004-03       Impact factor: 8.327

3.  Cognitive control and brain resources in major depression: an fMRI study using the n-back task.

Authors:  Philippe-Olivier Harvey; Philippe Fossati; Jean-Baptiste Pochon; Richard Levy; Guillaume Lebastard; Stéphane Lehéricy; Jean-François Allilaire; Bruno Dubois
Journal:  Neuroimage       Date:  2005-04-08       Impact factor: 6.556

4.  Persistent cognitive impairment in depression: the role of psychopathology and altered hypothalamic-pituitary-adrenocortical (HPA) system regulation.

Authors:  Simone Reppermund; Josef Zihl; Susanne Lucae; Sonja Horstmann; Stefan Kloiber; Florian Holsboer; Marcus Ising
Journal:  Biol Psychiatry       Date:  2006-12-22       Impact factor: 13.382

Review 5.  Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states.

Authors:  P W Gold; G P Chrousos
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

Review 6.  Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders.

Authors:  R M Sapolsky
Journal:  Arch Gen Psychiatry       Date:  2000-10

7.  Cortisol hypersecretion and cognitive impairment in depression.

Authors:  D R Rubinow; R M Post; R Savard; P W Gold
Journal:  Arch Gen Psychiatry       Date:  1984-03

Review 8.  Frontostriatal deficits in unipolar major depression.

Authors:  M A Rogers; J L Bradshaw; C Pantelis; J G Phillips
Journal:  Brain Res Bull       Date:  1998-11-01       Impact factor: 4.077

9.  Hippocampal atrophy in recurrent major depression.

Authors:  Y I Sheline; P W Wang; M H Gado; J G Csernansky; M W Vannier
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-30       Impact factor: 11.205

10.  Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed.

Authors:  B C Beats; B J Sahakian; R Levy
Journal:  Psychol Med       Date:  1996-05       Impact factor: 7.723

View more
  17 in total

Review 1.  Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review.

Authors:  Hannah R Snyder
Journal:  Psychol Bull       Date:  2012-05-28       Impact factor: 17.737

2.  Association of attentional shift and reversal learning to functional deficits in geriatric depression.

Authors:  Guy G Potter; Douglas R McQuoid; Martha E Payne; Warren D Taylor; David C Steffens
Journal:  Int J Geriatr Psychiatry       Date:  2012-01-24       Impact factor: 3.485

Review 3.  Specifying the neuropsychology of affective disorders: clinical, demographic and neurobiological factors.

Authors:  Thomas Beblo; Grant Sinnamon; Bernhard T Baune
Journal:  Neuropsychol Rev       Date:  2011-06-10       Impact factor: 7.444

4.  BDNF Val66Met polymorphism and stressful life events in melancholic childhood-onset depression.

Authors:  Timea Rimay; Istvan Benak; Eniko Kiss; Ildiko Baji; Agnes Feher; Anna Juhasz; John Strauss; James Kennedy; Cathy Barr; Maria Kovacs; Agnes Vetro; Krisztina Kapornai
Journal:  Psychiatr Genet       Date:  2015-12       Impact factor: 2.458

Review 5.  Neuropsychologic effects of neuromodulation techniques for treatment-resistant depression: a review.

Authors:  Jared L Moreines; Shawn M McClintock; Paul E Holtzheimer
Journal:  Brain Stimul       Date:  2010-02-11       Impact factor: 8.955

6.  Impaired visuospatial associative memory and attention in obsessive compulsive disorder but no evidence for differential dopaminergic modulation.

Authors:  Sharon Morein-Zamir; Kevin J Craig; Karen D Ersche; Sanja Abbott; Ulrich Muller; Naomi A Fineberg; Edward T Bullmore; Barbara J Sahakian; Trevor W Robbins
Journal:  Psychopharmacology (Berl)       Date:  2010-07-27       Impact factor: 4.530

7.  SSR149415, a non-peptide vasopressin V1b receptor antagonist, has long-lasting antidepressant effects in the olfactory bulbectomy-induced hyperactivity depression model.

Authors:  M E Breuer; M M van Gaalen; W Wernet; S E F Claessens; R S Oosting; B Behl; S M Korte; H Schoemaker; G Gross; B Olivier; L Groenink
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-31       Impact factor: 3.000

8.  Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features.

Authors:  Zeynep Kotan; Emre Sarandöl; Emine Kırhan; Güven Ozkaya; Selcçuk Kırlı
Journal:  Ther Adv Psychopharmacol       Date:  2012-04

Review 9.  Multifactorial determinants of the neurocognitive effects of electroconvulsive therapy.

Authors:  Shawn M McClintock; Jimmy Choi; Zhi-De Deng; Lawrence G Appelbaum; Andrew D Krystal; Sarah H Lisanby
Journal:  J ECT       Date:  2014-06       Impact factor: 3.635

10.  Response time variability and response inhibition predict affective problems in adolescent girls, not in boys: the TRAILS study.

Authors:  Patricia A M van Deurzen; Jan K Buitelaar; J Agnes Brunnekreef; Johan Ormel; Ruud B Minderaa; Catharina A Hartman; Anja C Huizink; Anne E M Speckens; A J Oldehinkel; Dorine I E Slaats-Willemse
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-02-22       Impact factor: 4.785

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.